StockData
Agenus Inc logo

Agenus Inc (AGEN) stock

AGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/30
$6.29−0.44 (-6.54%)

Close on Nov 16, 2026Market cap $283.18MP/E –Yield –

Agenus enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Agenus's enterprise value was $303.72M on Nov 10, 2026, against $173.61M a year earlier. Over the last 5 years it ranged from -$271.41M to $6.93B, with a median of $98.59M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 10, 2026$303.72M+139.1%
2025Dec 31, 2025$127.02M+161.6%
2024Dec 31, 2024$48.55M–
2023Jan 31, 2023-$182.62M–
2022Dec 30, 2022-$183.71M–
2021Dec 31, 2021-$240.58M-103.5%
2018Jan 31, 2018$6.93B+10.6%
2017Dec 29, 2017$6.27B-12.4%
2016Dec 30, 2016$7.16B+10.0%
2015Dec 31, 2015$6.51B–

More Agenus figures

See a number that looks wrong?